Table 1.
Demographic and disease-specific characteristics of subjects included in the analysis.
| UC with neoplasia (n=19) | UC without neoplasia (n=23) | |
|---|---|---|
| Sex | ||
| Female | 5 (26%) | 11(48%) |
| Male | 14 (74%) | 12(52%) |
|
| ||
| Race | ||
| African American | 2 (11%) | 2 (9%) |
| Asian | 1 (5%) | 1 (4%) |
| Caucasian | 16 (84%) | 20(87%) |
|
| ||
| Ethnicity | ||
| Hispanic | 0 | 2 (9%) |
| Not Hispanic | 19 (100%) | 21 (91%) |
|
| ||
| Median Age (IQR) | 49.1 years (40.4–59.3) | 51.7 years (38.5–57.1) |
|
| ||
| Median Disease | 17.3 (12.9–23.7) | 22.1 years (13–33.3) |
| Duration | ||
|
| ||
| PSC | 3 (16%) | 0 |
|
| ||
| Medications | ||
| Mesalamine | 12 | 15 |
| Immunomodulator | 2 | 6 |
| Anti-TNF | 0 | 4 |
| Anti-integrin | 1 | 0 |
| None | 4 | 1 |
|
| ||
| Disease Extent | ||
| Left-sided | 3 (16%) | 5 (22%) |
| Pancolitis | 16 (84%) | 18 (78%) |